Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2875375 | The Annals of Thoracic Surgery | 2013 | 8 Pages |
Abstract
Atrioventricular valve regurgitation is present in a subgroup of patients undergoing TAVI whose survival is impaired. The majority of surviving patients exhibit the clinical benefits of TAVI with amelioration of heart failure symptoms and a decrease in severity of atrioventricular valve regurgitation. At present, moderate or more severe atrioventricular valve regurgitation cannot be considered a contraindication for TAVI.
Keywords
TTESAVRSTSNYHABNPPAPAVAMPGLVEFTAVINew York Heart AssociationTransthoracic echocardiographyRight ventricularChronic obstructive pulmonary diseaseCOPDanalysis of varianceANOVAsurgical aortic valve replacementTricuspid regurgitationSociety of Thoracic SurgeonsMean pressure gradientconfidence intervalPulmonary artery pressureAtrial fibrillationaortic valve areamitral regurgitationtranscatheter aortic valve implantationleft ventricular ejection fraction
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Andrea MD, Sabine MD, PhD, Valerie MS, Anke MD, Ina MD, Domenico MD, Hendrik MD, Ruediger MD, PhD,